Aqua Bio Technology ASA (Oslo Axess: ABT) today announced that the company has improved its financial flexibility through a NOK 4 million loan from Innovation Norway.
"ABT is moving into a phase with increased commercial activity. In 2011 we redefined the distribution strategy for our cosmetic ingredient Aquabeautine XL®. We have succeeded in establishing distributor agreements covering all main markets. The additional financing enables us to take even better advantage of the commercial opportunities now available to us," said ABT CEO Arvid Lindberg.
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology ASA (ABT) (www.aquabiotechnology.com) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT's lead ingredient Aquabeautine XL® is a patented marine solution derived from the hatching fluid of salmon. The ingredient adds moisture and improves the renewal of skin cells in an effective and gentle manner, providing anti-aging effects. ABT is listed on the Oslo Stock Exchange's Axess market.
